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Summary Pulmonary function testing (PFT) has been used to evaluate the risk for
postoperative complications since the 1950s. PFT including spirometry, lung
volumes, diffusing capacity, oximetry, and arterial blood gases has been used to
assess the postoperative risk of lung resection. In selected cases, additional
evaluation may include radionuclide lung scanning, exercise testing, invasive
pulmonary hemodynamic measurements, and risk stratification analysis. A new
index, predicted postoperative product (PPP), was found to have strong predictive
ability for mortality. We defined a new useful index, measured product (MP), to
predict postoperative complications; MP had similar advantages of PPP. Since
diffusing capacity at rest has been shown to be a good predictor of postoperative
complications following lung resection, and since exercise testing has been also
useful in preoperative evaluation prior to lung resection, we reasoned that
evaluation of the effect of exercise on diffusing capacity would be helpful to
evaluate the ability of the pulmonary capillary bed to expand and increase its
capacity to transfer gas during exercise.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Currently, about 30% of patients undergoing lung
resection develop cardiopulmonary complications
with a 30-day mortality varying between 0.6% and
5%,1,2 depending on the extent of lung resection.
Recent mortality rates in two recent studies were
similar, 6.8% following pneumonectomy and 3.9%
following lobectomy in one study,1 and 5.7% after
pneumonectomy, 4.4% after bilobectomy, and 1.4%
after lesser resection in another study.2
Pulmonary function testing (PFT) has been used
to evaluate the risk for postoperative complications
since the 1950s. PFT including spirometry, lung
volumes, diffusing capacity, oximetry, and arterial
blood gases has been used to assess the post-
operative risk of lung resection. In selected cases,
additional evaluation may include radionuclide lung
scanning, exercise testing, invasive pulmonary
hemodynamic measurements, and risk stratifica-
tion analysis.
Preoperative lung evaluation including identifying
patients at risk, evaluating the risk, and finding
modified factors to decrease risk. This allows surgery
to be delayed in high-risk patients, and arranges
methods to decrease risk. Modern surgical proce-
dures have decreased complications, and allow high-
risk patients to undergo and survive surgery.
Methods used to evaluate patients prior
to lung resection
Since the first well-performed study of PFT in
candidates for lung surgery was published in 1955,3
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many attempts have been made to establish criteria
to predict postoperative mortality and cardiopul-
monary complications after lung resection. The
criteria used to select patients for major pulmonary
resections are based on clinical data, spirometry,
more detailed PFT, and cardiac evaluation.
Severe abnormalities detected by spirometry
indicate an increased risk of pulmonary resection
and should prompt further preoperative evaluation
and a critical assessment of the patient’s overall
condition.4 Patients with hypoxemia or hypercapnia
are at increased risk for morbidity or mortality
after thoracotomy.5 Lung volume determinations
may be helpful, and an increase in the ratio of
residual volume to total lung capacity is associated
with a high incidence of postoperative pulmonary
complications.6 Previously used tests to evaluate
differential function of each lung, such as bronch-
ospirometry7 and the lateral position test,8 have
been replaced by radionuclide lung scanning with
quantitative measurement of the contribution of
each lung to pulmonary ventilation and blood flow.9
The attractive features of radionuclide lung scan-
ning include its ready availability in general
hospitals, negligible risk to the patients, and a
fairly high degree of accuracy in the prediction of
postoperative pulmonary function.9 Pulmonary he-
modynamic measurements may be useful in se-
lected patients; a right ventricular ejection
fraction greater than or equal to 35%, a pulmonary
vascular resistance less than 200 dyne s cm5, and a
ratio (pulmonary vascular resistance/right ventri-
cular ejection fraction) less than 5.0 should be
associated with low morbidity and mortality after
lung resection.10 A resting saturation of less than
90%, or desaturation greater than or equal to 4%
during exercise are significantly predictive of
increased mortality and morbidity.11 Risk stratifica-
tion analysis, using a multifactorial cardiopulmon-
ary risk index based on conventional cardiac and
pulmonary clinical data, was highly predictive of
postoperative cardiopulmonary complications.12
Normal or close to normal preoperative spiro-
metry and CO pulmonary diffusing capacity (DLCO)
data indicate that the patient’s lung function
allows for surgery without further testing (Fig. 1).13
Patients with preoperative forced expiratory
volume in one second (FEV1) o60% predicted or
with DLCOo60% predicted, who are likely to
require lung resection, should be considered for
radionuclide lung scanning to estimate postopera-
tive spirometry and diffusing capacity. Results
showing predicted postoperative FEV1 and pre-
dicted postoperative DLCO greater than 40% pre-
dicted suggest an acceptable surgical risk, and the
patient should be referred accordingly. Patients
whose predicted postoperative results are less than
40% predicted, will require exercise testing to
assess maximal exercise capacity, maximal oxygen
uptake, and oxygen saturation. Patients with a
predicted postoperative FEV1 or predicted post-
operative DLCO greater than 35% of predicted
values and whose peak exercise oxygen uptake is
greater than 15ml/kg/min could be offered sur-
gery, with the goal of removing the smallest volume
of tissue that would be compatible with a cure.
Recently, Wyser et al.14 suggested that the im-
portant role of exercise testing maybe just after
spirometry and DLCO but before radionuclide
scanning. Besides, exercise testing can predict
postoperative complications with the same accu-
racy as radionuclide scanning but at a lower cost in
their study.
Clinical evaluation
Clinical factors have been suggested as significant
risk factors for postoperative pulmonary complica-
tions (Table 1). The most important risk factor is
the site of surgery.15 The closer the surgery is to the
diaphragm, the higher the complications. Surgical
duration lasting more than 2 h is associated with
complications, but not anesthesia.16 Less complica-
tions occur in laparoscopy approach.17 Age and
obesity have no definite association with complica-
tions. American Society of Anesthesiology score
including sputum cultures, pyrexia, and CXR
findings is strong predictor of complications.18
ARTICLE IN PRESS
>60% predicted 
< 60% predicted 
>40% predicted 
<40% predicted 
>15ml/min/kg  
<15ml/min/kg 
Pulmonary Function Test 
(FEV1 and DLCO) 
Quantitative Lung Scan 
(predicted postoperative 
 FEV1 and DLCO) 
Exercise Test 
(oxygen uptake) 
Other Option 
Surgery 
Figure 1 Diagrammatic approach to assessment of
operative risk for lung resection.
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Several studies show that nutrition, chronic ob-
structive pulmonary disease and smoking are risk
factors. Epstein has used simple cardiopulmonary
risk factor s on the base of an index to predict
complications (Table 2).12 These clinical factors
alter four major aspects of patient’s respiratory
status: lung volume, ventilatory pattern, gas
exchange, and respiratory defense mechanisms.19
PFT
Gaensler et al.3 showed that maximal voluntary
ventilation less than 50% of predicted and an FVC
less than 70% of predicted were associated with a
40% risk for death. The most common PFT used for
prediction is FEV1, and the percent predicted FEV1
is a more useful index because it accounts for
variability in the gender and size of patients for
lung resection. The important determinant of FEV1
cut-off value is the extent of lung resection. The
ability of lung function testing to predict post-
operative complications has been variable in pre-
vious studies. Patient selection, sample size, choice
of endpoints, and the retrospective design of some
studies are among the possible reasons for the
variable reports. Even in the presence of signifi-
cantly impaired lung function, most respirologists
would err on the side of recommending lung
resection for lung cancer in borderline cases,
because a decision not to operate almost always
will result in death from progressive cancer.
DLCO
The DLCO recently has been shown to be an
independent predictor of postoperative outcome.
DLCO was an important predictor of mortality and
postoperative complications.20,21 Patients with low
DLCO had an increased respiratory complication
rate after major pulmonary resection.22 In our
retrospective review of 151 pneumonectomy cases
done at Vancouver General Hospital from 1992 to
1997, patients with DLCOX70% predicted had a
much lower postpneumonectomy complication rate
(27 versus 94%) than patients with DLCOo70%
predicted.23
DLCO is a standard PFT used routinely in our
institution in the preoperative evaluation of pa-
tients for lung resection. Previous studies have
shown a clear relationship between a low diffusing
capacity and poor postoperative outcome after
lung resection.20,21,23 A low DLCO identifies pa-
tients with significant emphysema, and reduced
pulmonary capillary vascular bed. The mechanisms
that would predispose emphysematous lung to
develop pulmonary edema, include barotrauma
from lung ventilation,24 hyperperfusion of a dimin-
ished pulmonary microvascular bed leading to
endothelial damage from increased shear,25 seques-
tration of activated neutrophils and platelets,26
and postoperative pulmonary hypertension due to
the decreased pulmonary vascular bed following
lung resection.27 Poor right ventricular-pulmonary
arterial vascular coupling as a result of resection of
part of the pulmonary vascular tree, loss of
vascular compliance due to overdistension of the
remaining vessels by hyperperfusion, and occlusion
of the pulmonary capillary bed by activated
neutrophils and platelets, may impair cardiac
function28 and may lead to arrhythmias.29
Radionuclide lung scanning
This technique has been studied in the literature30
and found to be useful in preoperative evaluation,
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Table 1 Risk factors for postoperative cardiopul-
monary complications.
Nonpulmonary factors
Site of surgery
Duration of surgery
Laparoscopic approach
Nutrition
Age
Obesity
Pulmonary factors
American Society of Anesthesiology Score
COPD
Smoking
Table 2 The cardiopulmonary risk factors to
predict postoperative cardiopulmonary complica-
tions.
Cardiac
Congestive heart failure
Myocardiac infarction
Premature ventricular contraction
Arrhythmia
Age
Aortic stenosis
Poor condition
Pulmonary
Obesity
Smoking
Productive cough
Wheezing
FEV1/FVC
PaCO2
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especially prior to pneumonectomy, and in estimat-
ing the predicted postoperative FEV1 and DLCO.
One would expect that such a determination based
on the extent of pulmonary resection, the pre-
operative FEV1, the preoperative DLCO, and the
proportion of perfusion of the lung resected, would
be the preferred method. A new index, designated
the predicted postoperative product (PPP), ob-
tained by multiplying the percentage of predicted
postoperative FEV1 by the percentage of predicted
postoperative DLCO, was found by Pierce et al.20 to
have the strongest predictive ability for mortality.
The PPP is a new concept including values of
ventilatory function (FEV1), gas transfer (DLCO),
lung perfusion (radionuclide scanning), and the
resected lung into a single index. This index allows
a patient with a value below the threshold for one
criterion based on FEV1 or DLCO to be accepted for
surgery on the basis of a good value in the other.
Because this index uses percentage predicted
rather than absolute values for FEV1 and DLCO, it
can apply to patients of either gender across a wide
range of age, and height. A value o1650 by this
index was predictive of 7 of 8 deaths in the series of
Pierce et al.20 and of all 3 of the deaths in the series
of Markos et al.,31 so values o1650 could be
considered as indicating a high risk of mortality.
However, we calculated the predicted post-
operative values (without radionuclide scanning)
for FEV1 and DLCO from the surgical excision of
functional lung segments using the modified for-
mula of Nakahara et al.;32 predicted postoperative
(ppo) FEV1 determined in this manner has been
used in a recent study.33 We also used this formula
to calculate ppo DLCO. We validated the use of this
formula in our study in the 33 patients who had
postoperative lung function testing; the calculated
values of ppo FEV1 and DLCO% predicted were very
similar and not statistically significantly different
from the actually determined values.34 The ppo
values for FEV1 and DLCO enabled us to calculate
PPP from the preoperative data in all patients. The
calculated PPP was also useful in predicting post-
operative complications.
We defined a new useful index from spirometry
and DLCO, measured product (MP), obtained by
multiplying the percentage of predicted measured
preoperative FEV1 (from spirometry) by the per-
centage of predicted measured preoperative DLCO
(from DLCO) to predict postoperative complica-
tions.34 This simple and easy index MP (from
spirometry and DLCO) had similar advantages of
PPP, such as using percentage predicted rather than
absolute values and allowing a patient with a value
below the threshold for one criterion based on FEV1
or DLCO to be accepted for surgery on the basis of a
good value in the other. A value o5000 by this
index was predictive of 40 of 62 complications in
our study,34 so valueso5000 could be considered as
indicating a high risk of complications.
A predictive respiratory complication quotient,
combining predicted postoperative FEV1 and DLCO
together with the alveolar-arterial oxygen gradient
after a 2-min step climb in an index, of less than
2200 is related with increased risk for pulmonary
complications and mortality.35 The usefulness of
quantitative computed tomography scanning of the
chest comparing various techniques for estimating
predicted postoperative function was confirmed,36
but perfusion studies remained the most accurate.
Progressive exercise testing
Exercise testing stresses the entire cardiopulmon-
ary and oxygen delivery systems and assesses the
reserve that can be expected and may be needed
after surgery,37 and therefore may be useful in the
preoperative evaluation of patients with lung
cancer.38 Cardiopulmonary exercise testing has
been used extensively in the evaluating patients
with lung disease or dyspnea on exertion, in
assessing occupational impairment or disability, as
an integral component of pulmonary rehabilita-
tion,39 and in evaluating ambulatory patients with
heart failure being considered for cardiac trans-
plantation.40 The ability to exercise adequately has
also been used to assess the cardiopulmonary risk
of lung resection.37 Previous work has suggested
that an inability to perform minimal exercise or to
complete an exercise task is associated with an
increased risk for complications after lung resec-
tion.41 The theoretical value of exercise testing is
that it stresses the entire cardiopulmonary and
oxygen delivery systems, and assesses its physiolo-
gical capacity, which could enable one to deter-
mine the reserve that can be expected and may be
needed after surgery. According to Olsen37 in 1989,
the value of exercise testing had not yet been
substantiated completely, and the relationship
between preoperative exercise function and post-
operative outcome needed validation.
Patients incapable of exercising may be at
increased risk because of severe underlying
cardiopulmonary disease. Such disease may go
unrecognized preoperatively, because exercise
and cardiopulmonary stress may be limited by
noncardiopulmonary factors, only to become ob-
vious during the stress of the perioperative state.
Noncardiopulmonary factors limiting exercise, such
as impaired joint motility, muscle weakness or
amputation, arthritis or leg pain, claudication,
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dementia, or the inability to follow instructions,
may independently contribute to increased post-
operative risk. Exercise testing measures not only
cardiopulmonary fitness, but also nonphysiologic
factors, such as determination, perseverance, and
willingness to cooperate. An inability to cooperate
with postoperative care, or a low threshold for
tolerance of discomfort could lead to retained
secretions and an increased incidence of post-
operative complications. Such patients may devel-
op hypoxemia and increased work of breathing,
which might not only lead to pulmonary complica-
tions due to retained secretions, but could also
precipitate arrhythmias or congestive heart failure.
Exercise DLCO
Since diffusing capacity at rest has been shown to
be a good predictor of postoperative complications
following lung resection, and since exercise testing
has been also useful in preoperative evaluation
prior to lung resection, we reasoned that evalua-
tion of the effect of exercise on DLCO would be
helpful to evaluate the ability of the pulmonary
capillary bed to expand and increase its capacity to
transfer gas during exercise. Lack of an adequate
increase in DLCO during exercise would imply
inability of the pulmonary capillary bed to increase
with increasing cardiac output during exercise, and
would suggest increased likelihood of impairment
in gas exchange following lung resection. The
evaluation of the effect of exercise on DLCO has
not been previously used in the preoperative
evaluation of patients scheduled for lung resection.
The recent literature and our retrospective
review clearly demonstrated that DLCO is an
important predictor of postoperative complica-
tions.21,23 During physical exercise, both the
respiratory and cardiovascular systems are under
stress because of the increased oxygen requirement
of the working muscles and the increased carbon
dioxide elimination. An increase in this gas ex-
change implies a close coupling of pulmonary
ventilation and cardiovascular circulation. The
response of the cardiovascular and respiratory
systems to the increased gas exchange and venti-
latory and circulatory requirements in the
postoperative period may be evaluated by pre-
operative exercise testing, which would be ex-
pected to be useful in the preoperative evaluation
of patients with lung cancer. The mechanisms for
the increased DLCO during exercise include more
homogeneous distribution of red-cell transit time
within the capillary network as flow increases,42
dilatation of pulmonary blood capillaries, recruit-
ment of previously nonperfused pulmonary capil-
laries, more homogeneous vertical distribution of
pulmonary blood flow,43 greater utilization of
existing alveolar and capillary surface as lung
volume and pulmonary blood flow increase,44 and
increased arterial perfusion pressure.45 Thus, ex-
ercise may serve to identify subjects with subtle
diffusing defects who may still have a DLCO in the
‘‘normal’’ range at rest, but show limitation during
exercise. The use of exercise DLCO in addition to
clinical data, spirometric values, and lung function
assessments may result in improved prediction of
postoperative outcome following lung resection.
Our results suggested that the best variables in
predicting complications were exercise DLCO46–48
and ppo exercise DLCO also (unpublished data). We
measured diffusing capacity at rest and during
exercise in 571 patients undergoing resection for
lung cancer.46 Patients developing complications
had a lower diffusing capacity at rest, a smaller
increase in diffusing capacity during steady-state
exercise at 70% of maximum workload, and a lower
maximal oxygen consumption than did patients
without complications. The best predictor of
complications was the failure of diffusing capacity
while exercising to increase by more than 10% of
resting value: sensitivity, 78%; specificity, 100%.
The DLCO increase during exercise was most
conservative for estimating the function loss post-
operatively (unpublished data). It suggests that the
DLCO increase during exercise is more accurate in
estimating functional status. Thus, the decrease in
exercise capacity after lung resection cannot be
reflected by conventional lung function that over-
estimates the function loss.
Further considerations
The extent of pulmonary resection a patient can
tolerate should be determined preoperatively and
is based on both PFT and the patient’s performance
status. The size and location of the lesion by
computerized tomograph scan of the chest, and
bronchoscopy are helpful in determining how much
lung will be required for complete resection. Once
the amount of lung that is required for resection is
determined and the FEV1 and DLCO have been
assessed, the surgeon must decide if the patient
can tolerate resection. Prophylactic interventions
may be used to decrease the risk of perioperative
morbidity or mortality (Table 3). Preoperative
prophylactic interventions include smoking cessa-
tion, breathing training, antibiotics, expectorants,
bronchodilator therapy, and weight reduction.
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Intraoperative management includes limited an-
esthesia and thoracotomy times, intermittent
hyperinflation to prevent atelectasis, better con-
trol of secretions, prevention of aspiration, and
maintenance of bronchodilatation. Postoperative
measures include incentive spirometry, mobiliza-
tion of secretions, early ambulation, cough encour-
agement, and adequate pain control.
There have been significant advancements in
understanding cardiopulmonary physiology, surgical
technique, perioperative care, and nonsurgical
treatment modalities.49 Hypercapnia as a barrier
to lung resection has been overcome by success-
fully resecting lung tissue of selected patients in
chronic respiratory failure.50 Video-assisted thor-
acoscopic surgery may minimize postoperative
thoracic cage impairment and may further reduce
perioperative complications.50 Lung volume reduc-
tion surgery at the same time as surgery for lung
cancer can improve recovery of postoperative lung
function.51 Anesthetic agents with minimal respira-
tory and cardiac depression have led to early
extubation, which avoids tracheobronchitis and
nosocomial infection from prolonged mechanical
ventilation. Epidural anesthesia has helped reduce
postoperative pain and enables patients to clear
secretions by improved cough, ability to generate
deep inspirations, and early ambulation. Nonsedat-
ing analgesics are often used as a supplement to
epidural analgesia, thereby, further reducing the
risk of hypercapnia in these patients who are prone
to carbon dioxide retention. Minitracheostomy,
which is a percutaneous tracheal catheter inserted
at the bedside, allows for easy suctioning without
the morbidity of formal tracheostomy.52 The
increased availability of oxygen saturation monitors
enables one to frequently assess the patient’s
respiratory status without the need for repeated
artery blood gas sampling or an intensive care unit
setting.
Patients with lung cancer have a disease with
ultimately 100% mortality when left untreated and
if nonoperative therapy is ineffective. Lung resec-
tion, the best and potentially curative therapy,
carries risks, especially when performed on elderly
patients with coexistent cardiopulmonary disease.
Our study suggests that the use of exercise diffusing
capacity in preoperative assessment as an addi-
tional test prior to lung resection, will help define
patients at increased risk, for whom increased
effort at postoperative care may help to reduce
morbidity and mortality.46 This approach requires
further testing on a larger number of patients and
in other centers.
Patients whose lung function is below the safe
preoperative limits for lung resection should not be
completely rejected for surgical therapy, because
without surgery the outlook for lung cancer is poor.
They should be on intensive therapy to improve
lung function. They should be counseled as to the
risks of death or prolonged disability from surgery,
given other treatment options, and offered an
attempt at resection using all the postoperative
management skills if the risk for surgery is not
considered prohibitive. However, the previous
concept of threshold values for preoperative vari-
ables should be applied cautiously, especially since
lung volume resection surgery for emphysema
applied at the same time as surgery for lung
cancer51 may enable patients with poor lung
function due to emphysema to undergo surgery
for limited lung cancer.53
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